Q3 FY26 results approved, auditor gives clean (unmodified) report

Results View source PDF Explain this filing

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹106.40

prior close

₹108.15

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-0.4% vs market

Pharmaceuticals peers, median of 159sector+0.4%+0.2% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.5

15m

+0.5

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+1.0-0.4+0.4+0.2

Next day

+2.4+0.5+2.0+0.2+2.2

+2.3-0.0+2.3-0.0+2.3

-2.0-1.5-0.5-1.2-0.8

-3.2-2.2-1.0-1.7-1.5

+2.2-1.2+3.4-1.8+4.0

-1.2-2.4+1.2-2.6+1.4

15d

-6.4-8.8+2.4-7.0+0.6

-7.9-8.3+0.4-5.1-2.8

+4.7-3.5+8.3-3.5+8.2

+29.4+6.4+23.0+2.8+26.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board on Feb 10, 2026 approved standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025. Statutory auditor Price Waterhouse Chartered Accountants LLP issued a limited review report with an unmodified (clean) opinion. Specific revenue, profit or margin figures were not included in this cover filing.

Likely market impact

Routine quarterly submission with a clean auditor opinion, no accounting flags raised this quarter.